Advertisement

Gelenk- und Muskelschmerzen

  • Michael BernateckEmail author
  • Christina HeppnerEmail author
  • Peter Korsten
  • Heide Siggelkow
Living reference work entry

Latest version View entry history

Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Arthrosen sind die häufigsten Gelenkerkrankungen weltweit und führen zu einer Verschlechterung der Gelenkfunktion sowie zu akuten, intermittierenden oder chronischen Gelenkschmerzen. Muskelschmerzen sind die häufigste Ursache für Beschwerden im Bewegungssystem.

Literatur

  1. Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650PubMedCrossRefGoogle Scholar
  2. Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, PignoloD RJ, Sellmeyer E (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 31(1):16–35PubMedPubMedCentralCrossRefGoogle Scholar
  3. Adwan MH (2017) Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and the rheumatologist. Curr Rheumatol Rep 19(1):3PubMedCrossRefGoogle Scholar
  4. Aletaha D et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588Google Scholar
  5. Altman RD, Hochberg MC, Moskowitcz RW, Schnitzer TJ (2000) Recommendations for the medical management of Osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 43:1905–1915CrossRefGoogle Scholar
  6. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines (20 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2004) Hygiene in Klinik und Praxis, 3. Aufl. mhp-Verlag, Wiesbaden, S 51 ff. www.uni-duesseldorf.de/AWMF/: AWMF-Leitlinien-Register Nr. 029/006. Zugegriffen im 03.2012
  7. Anderson PA, FroyshteterW AB, Tontz L Jr (2013) Meta-analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. J Bone Miner Res 28(2):372–382PubMedCrossRefGoogle Scholar
  8. Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, MpofuH S, Richards B (2015) Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N Engl J Med 373(26):2534–2548PubMedCrossRefGoogle Scholar
  9. Bandolier Knowledge Library (2002) Paracetamol (acetaminophen) for osteoarthritis. www.jr2.ox.ac.uk/bandolier/booth/Arthritis/paraoa.htmzl. Zugegriffen im 03.2012
  10. Bandolier Monthly Journal (2000) Use of paracetamol in rheumatic disease. www.jr2.ox.ac.uk/bandolier/band76/b76-5.html. Zugegriffen im 03.2012
  11. Bardin T (2003) Gonococcal arthritis. Best Pract Res Clin Rheumatol 17(2):201–208PubMedCrossRefGoogle Scholar
  12. Baron R, Eberhart L, Kern K et al (2017) Tapentadol prolonged release for chronic pain: a review of clinical trials and 5 years of routine clinical practice data. Pain Pract 17(5):678–700PubMedCrossRefGoogle Scholar
  13. Baumbach SF, Böcker W, Mutschler W, Schieker M (2012) Warum bricht die Wirbelsäule wo sie bricht? Osteologie 21:143–150CrossRefGoogle Scholar
  14. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G (2005) Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 18:367–374Google Scholar
  15. Berenbaum F (2008) New horizons and perspectives in the treatment of osteoarthritis. Arthritis Res Ther 10:441–449CrossRefGoogle Scholar
  16. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, EriksenS EF, Cummings R (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809–1822PubMedCrossRefGoogle Scholar
  17. Bodmann K-F, Grabein B, Kresken M, Derendorf H, Stahlmann R, Ott SR, Olzowy B, Eckmann C, Wagenlehner F, Sunderkötter C, Voßen M, Dohmen PM, Shah PM, Mutters R, Walger P, Wilke M (2018). S2K Leitlinie: Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen – Update 2018 http://www.awmf.org/uploads/tx_szleitlinien/S82-006l_S2k_Parenterale_Antibiotika_2018-1.pdf. Zugegriffen am 26.02.2018
  18. Braun J et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904PubMedPubMedCentralCrossRefGoogle Scholar
  19. Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, Graves S, Staples MP, Murphy B (2009) A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 361(6):557–568PubMedCrossRefGoogle Scholar
  20. Burmester G, Lanas A, Biasucci L et al (2011) The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis 70:818–822PubMedCrossRefGoogle Scholar
  21. Buttgereit F, Burmester G, Bijlsma JW (2005) Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA. Ann Rheum Dis 64:170–172Google Scholar
  22. Buttgereit F, Mehta D, Kirwan J et al (2013) Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis 72:204–210PubMedCrossRefGoogle Scholar
  23. Cannon CP, Curtis SP, FitzGerald GA, Krum H, Bolognese JA, Bombardier C, Weinblatt ME, van der Heijde D, Laine L (2006) Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 18(9549):1771–1781CrossRefGoogle Scholar
  24. Chan FK, Lanas A, Scheiman J et al (2010) Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomized trial. Lancet 376(9736):173–179PubMedCrossRefGoogle Scholar
  25. Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR Jr, Budiman-Mak E, Balestra DJ, Blackburn WD, Cannon GW, Inman RD, Alepa FP, Mejias E, Cohen MR, Makkena R, Mahowald ML, Higashida J, Silverman SL, Parhami N, Buxbaum J, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Henderson WG et al (1996) Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter’s syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39(12):2021–2027PubMedCrossRefGoogle Scholar
  26. Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O’Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, TuongC W, Ritchlin T (2016a) Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheum 68(5):1060–1071Google Scholar
  27. Coates LC, Murphy R, Helliwell PS (2016b) New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation. Br J Dermatol 174:1174–1178.  https://doi.org/10.1111/bjd.14667CrossRefPubMedGoogle Scholar
  28. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381PubMedPubMedCentralCrossRefGoogle Scholar
  29. Creamer P (1999) Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol 11:417–421PubMedCrossRefGoogle Scholar
  30. Dachverband Osteologie (2011) DVO guideline 2009 for prevention, diagnosis and therapy of osteoporosis in adults. Osteologie 20:55–74CrossRefGoogle Scholar
  31. Dachverband Osteologie in Deutschland (DVO) (2017) Evidenz-basierte Empfehlungen zur Prävention und Therapie der Osteoporose. www.dv-osteologie.org. Zugegriffen im 03.2012
  32. Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev (1):CD002822Google Scholar
  33. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21(7):1151–1154PubMedCrossRefGoogle Scholar
  34. Derendorf H, Mollmann H, Gruner A, Haack D, Gyselby G (1986) Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther 39:313–317PubMedCrossRefPubMedCentralGoogle Scholar
  35. Derry S, Moore RA, Rabbie R (2012) Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev (9):CD007400.  https://doi.org/10.1002/14651858.CD007400.pub2. Zugegriffen im 03.2012
  36. Dt. Ges. f. Orthopädie und Traumatologie u. Berufsverb. d. Ärzte f. Orthopädie (Hrsg) (2002) Intraartikuläre Punktionen und Injektionen. Leitlinien der Orthopädie, 2. Aufl. Dt. Ärzte-Verlag, KölnGoogle Scholar
  37. Echtermeyer F, Bertrand J, Dreier R, Meinecke I et al (2009) Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown osteoarthritis. Nat Med 15:1072–1076PubMedCrossRefGoogle Scholar
  38. Favero M, Schiavon F, Riato L, Carraro V, Punzi L (2008) Rheumatoid arthritis is the major risk factor for septic arthritis in rheumatological settings. Autoimmun Rev 8(1):59–61PubMedCrossRefGoogle Scholar
  39. Fiehn C, Holle J, Iking-Konert C et al (2018) S2e-Leitlinie: Therapie der rheumatoiden Arthritis mit krankheitsmodifizierenden Medikamenten. Z Rheumatol 77(Suppl 2):35PubMedCrossRefGoogle Scholar
  40. Fransen M, McConnell S, Hernandez-Molina G, Reichenbach S (2010) Does land-based exercise reduce pain and disability associtated with hip osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthr Cartil 18:613–620PubMedCrossRefPubMedCentralGoogle Scholar
  41. Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Ustianowski AP, Helbert M, Watson KD, LuntD M, Symmons P (2011) Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 70(10):1810–1814PubMedPubMedCentralCrossRefGoogle Scholar
  42. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BE, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B, Delmas PD, Dequeker J, Ragi Eis S, Gennari C, Johnell O, Johnston CC Jr, Lau EM, Liberman UA, Lindsay R, Martin TJ, Masri B, Mautalen CA, Meunier PJ, Khaltaev N et al (1999) Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10(4):259–264PubMedCrossRefGoogle Scholar
  43. Gossec L et al (2012) European league against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 71:4–12PubMedCrossRefGoogle Scholar
  44. Gotzsche PC, Johansen HK (1998) Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis. BMJ 316:811–818PubMedPubMedCentralCrossRefGoogle Scholar
  45. Haibel H, Fendler C, Listing J, Callhoff J, Braun J, Sieper J (2014) Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial. Ann Rheum Dis 73(1):243–246PubMedCrossRefGoogle Scholar
  46. Haroon NN, Paterson JM, Li P, Inman RD, Haroon N (2015) Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med 163(6):409–416PubMedCrossRefGoogle Scholar
  47. Häuser W, Bock F, Engeser P, Hege-Scheuing G, Hüppe M, Lindena G, Maier C, Norda H, Radbruch L, Sabatowski R, Schäfer M, Schiltenwolf M, Schuler M, Sorgatz H, Tölle T, Willweber-Strumpf A, Petzke F (2015) Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain. Schmerz 29(1):109–130PubMedCrossRefGoogle Scholar
  48. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P, American College of Rheumatology (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 64(4):465–474CrossRefGoogle Scholar
  49. Hochberg MC, Martel-Pelletier J, Monfort J et al (2016) Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis 75(1):37–44PubMedCrossRefGoogle Scholar
  50. Hunter JA, Blyth TH (1999) A risk-benefit assessment of intra-articular corticosteroids in rheumatic disorders. Drug Saf 21:353–365PubMedCrossRefGoogle Scholar
  51. Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, Edwards R, Gray LA, Stout L, Owen S, Hollingworth W, Ghdoke B, Annesley-Williams DJ, RalstonJ SH, Jarvik G (2009) A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 361(6):569–579PubMedPubMedCentralCrossRefGoogle Scholar
  52. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9(8):1137–1141PubMedCrossRefPubMedCentralGoogle Scholar
  53. Karreman MC, Luime JJ, Hazes JMW, Weel A (2017) The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 11(5):631–642PubMedGoogle Scholar
  54. Kendler DL, Bauer DC, Davison KS, Dian L, Hanley DA, Harris ST, McClung MR, Miller PD, Schousboe JT, YuenE CK, Lewiecki M (2016) Vertebral fractures: clinical importance and management. Am J Med 129(2):221. e1–e10CrossRefGoogle Scholar
  55. Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Moricke R, Lopez-Romero P (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391(10117):230–240.  https://doi.org/10.1016/S0140-6736(17)32137-2CrossRefGoogle Scholar
  56. Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O’Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sandor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30(1):3–23PubMedCrossRefGoogle Scholar
  57. Kiltz U, Alten R, Fleck M, Krüger K, Manger B, Müller-Ladner U, Nüsslein H, Reuss-Borst M, Schwarting A, Schulze-Koops H, Tausche A, Braun J (2016) Langfassung zur S2e-Leitlinie Gichtarthritis (fachärztlich). AWMF-Leitlinie 060/005. http://www.awmf.org/leitlinien/detail/ll/060-005.html. Zugegriffen am 02.03.2018PubMedCrossRefGoogle Scholar
  58. Kiltz U, Baraliakos X, Regel A, Buhring B, Braun J (2017) Causes of pain in patients with axial spondyloarthritis. Clin Exp Rheumatol 35 Suppl 107(5):102–107PubMedGoogle Scholar
  59. Kirwan JR (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The arthritis and rheumatism council low-dose glucocorticoid study group. N Engl J Med 333:142–146PubMedCrossRefGoogle Scholar
  60. Knopp JA, Diner BM, Blitz M, LyritisB GP, Rowe H (2005) Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int 16(10):1281–1290PubMedCrossRefGoogle Scholar
  61. Köhm M, Behrens F (2017) Psoriasisarthritis : Aktuelle therapeutische Standards. Z Rheumatol 76(6):495–503PubMedCrossRefGoogle Scholar
  62. Kroon FP, van der Burg LR, Ramiro S, Landewe RB, Buchbinder R, Falzon L, van der Heijde D (2015) Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev (7):CD010952Google Scholar
  63. Krüger K, Wollenhaupt J, Burmester GR et al (2012) S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der Rheumatoiden Arthritis. Z Rheumatol 71:592–603PubMedCrossRefGoogle Scholar
  64. Kuo CF, See LC, Yu KH, Chou IJ, ChiouS MJ, Luo F (2013) Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford) 52(1):127–134CrossRefGoogle Scholar
  65. Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11(11):649–662PubMedCrossRefGoogle Scholar
  66. KVWL kompakt Nr. 55, 1/2017.; https://www.kvwl.de/mediathek/son/pdf/2017/kompakt_e55.pdf. Zugegriffen am 04.11.2017
  67. Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP (2007) Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Longterm (MEDAL) programme: a randomised comparison. Lancet 10(9560):465–473CrossRefGoogle Scholar
  68. Lange U (2015) Physiotherapy in rheumatology. Z Rheumatol 74(8):701–708PubMedCrossRefGoogle Scholar
  69. Leder BZ, Tsai JN, Jiang LA, Lee H (2017) Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: the Denosumab and Teriparatide Follow-up study (DATA-Follow-up). Bone 98:54–58PubMedCrossRefGoogle Scholar
  70. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320–323PubMedCrossRefGoogle Scholar
  71. Lippuner K, Johansson H, Kanis JA, Rizzoli R (2009) Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int 20(7):1131–1140PubMedCrossRefGoogle Scholar
  72. Löffler C, Sattler H, Peters L, Loffler U, Uppenkamp M, Bergner R (2015) Distinguishing gouty arthritis from calcium pyrophosphate disease and other arthritides. J Rheumatol 42(3):513–520PubMedCrossRefGoogle Scholar
  73. Loock J, Haustedt N, Wollenhaupt J (2014) Septische Arthritis des Erwachsenen. Z Rheumatol 73(7):623–633; quiz 634–625PubMedCrossRefGoogle Scholar
  74. MacPherson H, Vertosick EA, Foster NE, Lewith G, Linde K, Sherman KJ, Witt CM, Vickers AJ (2017) The persistence of the effects of acupuncture after a course of treatment: a meta-analysis of patients with chronic pain. Pain 158(5):784–793.  https://doi.org/10.1097/j.pain.0000000000000747CrossRefPubMedPubMedCentralGoogle Scholar
  75. Margaretten ME, Kohlwes J, Moore D, Bent S (2007) Does this adult patient have septic arthritis? JAMA 297(13):1478–1488PubMedCrossRefGoogle Scholar
  76. Martinez-Ferrer A, Blasco J, Carrasco JL, Macho JM, Roman LS, Lopez A, Monegal A, Guanabens N, Peris P (2013) Risk factors for the development of vertebral fractures after percutaneous vertebroplasty. J Bone Miner Res 28(8):1821–1829PubMedCrossRefGoogle Scholar
  77. Mathews C, Coakley JG (2008) Septic arthritis: current diagnostic and therapeutic algorithm. Curr Opin Rheumatol 20(4):457–462PubMedCrossRefGoogle Scholar
  78. Maugars Y, Mathis C, Berthelot JM, Charlier C, Prost A (1996) Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study. Br J Rheumatol 35(8):767–770PubMedCrossRefGoogle Scholar
  79. Modi A, Siris ES, Tang J, Sen S (2015) Cost and consequences of noncompliance with osteoporosis treatment among women initiating therapy. Curr Med Res Opin 31(4):757–765PubMedCrossRefGoogle Scholar
  80. Moll J, Wright MV (1973) Psoriatic arthritis. Semin Arthritis Rheum 3(1):55–78PubMedCrossRefGoogle Scholar
  81. Moore RA, Tramèr MR, Carroll D, Wiffen PJ, McQuay HJ (1998) Quantitive systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316:333–338PubMedPubMedCentralCrossRefGoogle Scholar
  82. Morgan DS, Fisher D, MerianosB A, Currie J (1996) An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect 117(3):423–428PubMedPubMedCentralCrossRefGoogle Scholar
  83. National Institute for Health and Care Excellence (2013) Vertebral fractures-vertebroplasty and kyphoplasty (TA279). http://guidance.nice.org.uk/TA279. Zugegriffen am 04.11.2017
  84. Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, GlassJ EV, Krege H (2006) Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporos Int 17(2):273–280PubMedCrossRefGoogle Scholar
  85. Odio CM, Ramirez T, Arias G, Abdelnour A, Hidalgo I, Herrera ML, Bolanos W, Alpizar J, Alvarez P (2003) Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children. Pediatr Infect Dis J 22(10):883–888PubMedCrossRefGoogle Scholar
  86. Office of the Surgeon General (US) (2004) Bone health and osteoporosis: a report of the surgeon general. www.ncbi.nlm.nih.gov/books/NBK45513/. Zugegriffen am 04.11.2017
  87. Petrella RJ, Petrella M (2006) A prospective randomized, double-blind, placebo-controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol 33:951–956PubMedGoogle Scholar
  88. Pfeifer M, Gehlen M, Hinz C (2017) Spinal orthoses in the treatment of vertebral fractures with osteoporosis: a systematic review article. Z Rheumatol 76(10):860–868PubMedCrossRefGoogle Scholar
  89. Piper JM, Ray WA, Daughterty JR, Griffin MR (1991) Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 114:735–740PubMedCrossRefGoogle Scholar
  90. Poddubnyy D, Sieper J (2014) Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment. Curr Opin Rheumatol 26(4):377–383PubMedCrossRefGoogle Scholar
  91. Rau R, Wassenberg S, Zeidler H, LDPT-Study Group (2000) Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis – preliminary results of a multicenter, randomized, parallel, double blind study. Z Rheumatol 59(Suppl 2):II/90–II/96CrossRefGoogle Scholar
  92. Rees F, Hui M, Doherty M (2014) Optimizing current treatment of gout. Nat Rev Rheumatol 10(5):271–283PubMedCrossRefGoogle Scholar
  93. Reveille JDM, Weisman H (2013) The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci 345(6):431–436PubMedPubMedCentralCrossRefGoogle Scholar
  94. Richter K, Müller-Ladner U, Dischereit G, Lange U (2017, issn 1573-3971/1875-6360) Potentials and limits of physiotherapy in osteoarthritis. Curr Rheumatol Rev 13:1–6.  https://doi.org/10.2174/1573397113666170810151638CrossRefGoogle Scholar
  95. Ritchlin CT, ColbertD RA, Gladman D (2017) Psoriatic arthritis. N Engl J Med 376(10):957–970PubMedCrossRefGoogle Scholar
  96. Rudwaleit M (2017) Spondyloarthritiden. Z Rheumatol 76(10):889–903PubMedCrossRefGoogle Scholar
  97. Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52:1000–1008.  https://doi.org/10.1002/art.20990CrossRefPubMedGoogle Scholar
  98. Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, Sorensen IJ, Valle-Onate R, Weber U, Wei J, Sieper J (2011) The assessment of spondyloArthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25–31PubMedCrossRefGoogle Scholar
  99. Sarawate CA, Patel PA, Schumacher HR, Yang W, BrewerA KK, Bakst W (2006) Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol 12(2):61–65PubMedCrossRefGoogle Scholar
  100. Sattui SEK, Saag G (2014) Fracture mortality: associations with epidemiology and osteoporosis treatment. Nat Rev Endocrinol 10(10):592–602PubMedCrossRefGoogle Scholar
  101. Schett G, Lories RJ, D’Agostino MA, Elewaut D, Kirkham B, Soriano ER, McGonagle D (2017) Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol 13(12):731–741PubMedCrossRefGoogle Scholar
  102. Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, Hofman A, Uitterlinden AG, van Leeuwen JP, Pols HA (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 34(1):195–202PubMedCrossRefGoogle Scholar
  103. Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Howe TS, van der Meulen MC, WeinsteinM RS, Whyte P (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29(1):1–23PubMedCrossRefGoogle Scholar
  104. Sharff KA, RichardsJ EP, Townes M (2013) Clinical management of septic arthritis. Curr Rheumatol Rep 15(6):332PubMedCrossRefGoogle Scholar
  105. Sieper J, Poddubnyy D (2016) New evidence on the management of spondyloarthritis. Nat Rev Rheumatol 12(5):282–295PubMedCrossRefGoogle Scholar
  106. Sieper J, van der Heijde D, Landewe R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Rudwaleit M (2009) New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 68(6):784–788PubMedCrossRefGoogle Scholar
  107. Smolen JS, Schols M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landewe R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, Bosch FVD, Coates LC, Emery P, Gensler LS, Gossec L, Helliwell P, Jongkees M, Kvien TK, Inman RD, McInnes IB, Maccarone M, Machado PM, Molto A, Ogdie A, Poddubnyy D, Ritchlin C, Rudwaleit M, Tanew A, Thio B, Veale D, VlamD K, Heijde V (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis 77(1):3–17PubMedCrossRefGoogle Scholar
  108. Sommer C, Alten R, Bär K-J, Bernateck M, Brückle W, Friedel E, Henningsen P, Petzke F, Tölle T, Üçeyler N (2017) Medikamentöse Therapie des Fibromyalgiesyndroms. Schmerz 31(3):274–28431  https://doi.org/10.1007/s00482-017-0207-0PubMedCrossRefGoogle Scholar
  109. Song IH, Poddubnyy DA, Rudwaleit M, Sieper J (2008) Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs. Arthritis Rheum 58(4):929–938PubMedCrossRefGoogle Scholar
  110. Stephan M, Karst M, Bernateck M (2015) Drug strategies in the treatment of chronic pain. Fortschr Neurol Psychiatr 83(7):402–413PubMedCrossRefGoogle Scholar
  111. Stolwijk C, Boonen A, van Tubergen A, Reveille JD (2012) Epidemiology of spondyloarthritis. Rheum Dis Clin N Am 38(3):441–476CrossRefGoogle Scholar
  112. Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, White WB, Lipsky PE, Horowitz Z, Huang W, Maroli AN, Waltrip RW 2nd, HamburgerM SA, Becker A (2011) Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 306(7):711–720PubMedCrossRefGoogle Scholar
  113. Tande A, Patel JR (2014) Prosthetic joint infection. Clin Microbiol Rev 27(2):302–345PubMedPubMedCentralCrossRefGoogle Scholar
  114. Taurog JD, ChhabraR A, Colbert A (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374(26):2563–2574PubMedCrossRefGoogle Scholar
  115. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673PubMedCrossRefGoogle Scholar
  116. Taylor TH, Mecchella JN, Larson RJ, KerinT KD, Mackenzie A (2012) Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial. Am J Med 125(11):1126–1134 e1127PubMedCrossRefGoogle Scholar
  117. Terkeltaub RA, Furst DE, Bennett K, Kook KA, CrockettM RS, Davis W (2010) High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 62(4):1060–1068PubMedCrossRefGoogle Scholar
  118. Towheed TE, Judd MJ, Hochberg MC, Wells G (2004) Acetaminophen for osteoarthritis (Cochrane review). The Cochrane library, issue 1. Wiley, ChichesterGoogle Scholar
  119. Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Guanabens N, Obermayer-Pietsch B, Ralston SH, EastellM R, Zillikens C (2017) Discontinuation of Denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone 105:11–17PubMedCrossRefGoogle Scholar
  120. Tubergen, A van (2015). The changing clinical picture and epidemiology of spondyloarthritis. Nat Rev Rheumatol 11(2): 110-118.Google Scholar
  121. Varkas G, Van den Bosch F (2016) NSAIDs in axial spondyloarthritis: to be continued..? Ann Rheum Dis 75(8):1423–1425PubMedCrossRefGoogle Scholar
  122. Venmans A, Klazen CA, Lohle PN, van Rooij WJ, Verhaar HJ, de Vries J, Mali WP (2010) Percutaneous vertebroplasty and pulmonary cement embolism: results from VERTOS II. AJNR Am J Neuroradiol 31(8):1451–1453PubMedCrossRefGoogle Scholar
  123. Wang R, DasguptaM A, Ward M (2016) Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials. Ann Rheum Dis 75(6):1152–1160PubMedCrossRefGoogle Scholar
  124. Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L (2016) American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheum 68(2):282–298CrossRefGoogle Scholar
  125. Wassenberg S, Rau R, Steinfeld P, Zeidler H (2005) Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 52:3371–3380PubMedCrossRefGoogle Scholar
  126. Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M (1999) Clinical features and outcome of septic arthritis in a single UK Health District 1982–1991. Ann Rheum Dis 58(4):214–219PubMedPubMedCentralCrossRefGoogle Scholar
  127. WHO (1994) Assessment of fracture risk and and its application to screening for postmenopausal osteoporosis. WHO, GenevaGoogle Scholar
  128. Zulian F, Martini G, Gobber D, Agosto C, Gigante C, Zacchello F (2003) Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. J Rheumatol 42:1254–1259CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Zentrum für Rheumatologie & Schmerzmedizin HannoverHannoverDeutschland
  2. 2.MVZ endokrinologikum GöttingenGöttingenDeutschland
  3. 3.Klinik für Nephrologie und RheumatologieUniversitätsmedizin GöttingenGöttingenDeutschland
  4. 4.Osteologisches Zentrum DVOMVZ endokrinologikum GöttingenGöttingenDeutschland
  5. 5.Klinik für Gastroenterologie und EndokrinologieUniversitätsmedizin GöttingenGöttingenDeutschland

Personalised recommendations